Why the study?
Does Enhanced recovery after surgery (ERAS) improve outcomes in patients undergoing elective primary total joint arthroplasty (TJA)?
Does Enhanced recovery after surgery (ERAS) improve outcomes in patients undergoing elective primary total joint arthroplasty (TJA)?
ERAS protocols in total joint arthroplasty are associated with reduced length of stay and costs without increasing readmissions, though further standardization and robust prospective trials are needed.
Enhanced recovery after surgery (ERAS) is an evidence-based, multidisciplinary, multimodal, and continuously audited approach to the care of the surgical patient [1,2]. Pioneered in 2001 for colorectal surgery [3], ERAS programs have since been developed and implemented for a variety of diseases and surgical procedures. In elective primary total joint arthroplasty (TJA), patients in ERAS pathways have been shown to have lower cost, mortality, and length of stay (LOS) with no subsequent increase in readmissions in comparison to non-ERAS cohorts [4–7].
No takes yet. Share an insight, caveat, or question.
Morrell et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: